Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

August 8, 2008

byetta / LAR will be multi-billion dollar drug

This analysis is solely the work of the author. It has not been edited or endorsed by GLG.
Analysis By:
Implications: This was a great NYT story.  The fact that Byetta was suggested as cardioprotective out of ACCORD was truly ignored by the media and nice to see the suggestion here. FDA is moving much more this direction and from a patient perspective, having a cardioprotective drug (LAR) that is easier to take than insulin (no hypo, no weight gain, 2% A1c drop) will be shown to be revolutionary. 

Analysis: This will ultimately be a positive for Amylin and Alkermes.

Other Analyses of the Same Source Article:
Byetta saves lives
August 18, 2008, Author: GLG Expert Contributor
Promising start but more data needed
August 18, 2008, Author: GLG Expert Contributor
Byetta - what needs to be done
August 15, 2008, Author: GLG Expert Contributor
Life-extending effect of Byetta ?
August 13, 2008, Author: GLG Expert Contributor
Random finding does justify change in Byetta prescribing
August 11, 2008, Author: GLG Expert Contributor
Byetta sale will remain assuch or decrease
August 11, 2008, Author: GLG Expert Contributor
Byetta Preventing Mortality? Even IF True, Wrong Formulation?
August 11, 2008, Author: GLG Expert Contributor

Report a Concern

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-01T13:45:22.747